As previously reported, Mizuho upgraded Universal Health to Buy from Neutral with a $138 price target. Analyst Sheryl Skolnick said the failure of the GOP to move on ACA repeal out of the House, will result in the continuation of the important benefit of Medicaid expansion and without a near-or medium-term threat of block grants. Additionally, the analyst views Universal Health as undervalued given strong volumes and free cash flow.
Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSImpinj (PI) up... To see the rest of the story go to thefly.com. See Story Here